ET CETERA
Somatek will host a fun, casual evening for members of the San Diego life sciences community. Get connected, network, and share ideas. The event will be on Thursday, February 29 · 4:30 – 7:30pm PST at Somatek’s facility – 9466 Black Mountain Rd Suite 130...
BIOLOGICS, NEWS
We are so happy to learn that the IPO of our former client CG Oncology went exceedingly well. After recent news that GC Oncology’s bladder cancer treatment received both FDA fast track and breakthrough therapy designation, this is more good news for people with...
BIOLOGICS
Somatek is attending 2023 BioProcess International US West. The conference takes place from February 27 – March 2 at the San Diego Convention Center under the headline ACCELERATE SPEED TO MARKET FOR YOUR NEXT GENERATION MABS, VACCINES AND CELL/GENE THERAPY...
BIOLOGICS
This post and a huge thank you to David Sergeant and Justin Foox of Ipratech has been overdue for some time. Early last year, Somatek acquired a CYTOSYS control platform for its process development work. Having experience with bioreactor controllers from several other...
BIOLOGICS
The Janssen Pharmaceutical Companies of Johnson & Johnson, together with a consortium of global partners, on Wednesday announced the results of an independent, scheduled data review of the Phase 3 Mosaico study of Janssen’s investigational HIV vaccine regimen. The...
